Showing results (31-40 of 58) with videos related to
Sort By:
Pageof 6
Drug Delivery and Translational Research|March 20, 2015
Identification and characterization of a novel scFv recognizing human and mouse CD133Suresh Kumar Swaminathan, Lin Niu, Nate Waldron, et al.Scientific Reports|January 25, 2019
Identification of candidate neoantigens produced by fusion transcripts in human osteosarcomasSusan K Rathe, Flavia E Popescu, James E Johnson, et al.Journal of Neurosurgery|September 25, 2007
Improved distribution of small molecules and viral vectors in the murine brain using a hollow fiber catheterSeunguk Oh, Rick Odland, Scott R Wilson, et al.Journal of Neurosurgery|July 21, 2007
Efficacy of nonviral gene transfer in the canine brainSeunguk Oh, G Elizabeth Pluhar, Elizabeth A McNeil, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 3, 2013
CD8+ T cell-independent tumor regression induced by Fc-OX40L and therapeutic vaccination in a mouse model of gliomaKatherine A Murphy, Jami R Erickson, Charles S Johnson, et al.Bioinformatics (Oxford, England)|July 5, 2013
MMuFLR: missense mutation and frameshift location reporterSusan K Rathe, James E Johnson, Kevin A T Silverstein, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 23, 2013
Immunogenicity of murine solid tumor models as a defining feature of in vivo behavior and response to immunotherapyMelissa G Lechner, Saman S Karimi, Keegan Barry-Holson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2010
Role of type 1 IFNs in antiglioma immunosurveillance--using mouse studies to guide examination of novel prognostic markers in humansMitsugu Fujita, Michael E Scheurer, Stacy A Decker, et al.Cancer Chemotherapy and Pharmacology|March 10, 2012
9-Amino acridine pharmacokinetics, brain distribution, and in vitro/in vivo efficacy against malignant gliomaAaron M Teitelbaum, Jose L Gallardo, Jessica Bedi, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2005
Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastomaJohn R Ohlfest, Zachary L Demorest, Yasuhiko Motooka, et al.Pageof 6